Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Brand

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Scientific Reports|March 11, 2018
ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRAKatrin Schelleckes, Boris Schmitz, Malte Lenders, et al.
Journal of the American Society of Nephrology : JASN|May 3, 2015
Serum-Mediated Inhibition of Enzyme Replacement Therapy in Fabry DiseaseMalte Lenders, Jörg Stypmann, Thomas Duning, et al.
Frontiers in Physiology|July 21, 2018
The Yo-Yo Intermittent Tests: A Systematic Review and Structured Compendium of Test ResultsBoris Schmitz, Carina Pfeifer, Kiana Kreitz, et al.
Frontiers in Physiology|February 18, 2020
Sex Differences in High-Intensity Interval Training-Are HIIT Protocols Interchangeable Between Females and Males?Boris Schmitz, Hannah Niehues, Lothar Thorwesten, et al.
The Journal of Sports Medicine and Physical Fitness|February 24, 2017
Yo-Yo IR1 vs. incremental continuous running test for prediction of 3000-m performanceBoris Schmitz, Andreas Klose, Katrin Schelleckes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 29, 2016
Renal function predicts long-term outcome on enzyme replacement therapy in patients with Fabry diseaseMalte Lenders, Boris Schmitz, Jörg Stypmann, et al.
Plos One|August 30, 2014
Large vessel adventitial vasculitis characterizes patients with critical lower limb ischemia with as compared to without human immunodeficiency virus infectionMartin Brand, Angela J Woodiwiss, Frederic Michel, et al.
Chirurgia (Bucharest, Romania : 1990)|July 9, 2018
Managing Infected Pancreatic NecrosisJohn-Edwin Thomson, Sven M Van Dijk, Martin Brand, et al.
Pancreas|November 20, 2018
Transient Expression of Interleukin-21 in the Second Hit of Acute Pancreatitis May Potentiate Immune Paresis in Severe Acute PancreatitisJohn-Edwin Thomson, Ekene E Nweke, Martin Brand, et al.
Frontiers in Cardiovascular Medicine|November 29, 2023
Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry diseaseChristian Pogoda, Stefan-Martin Brand, Thomas Duning, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Scientific Reports|March 11, 2018
ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRAKatrin Schelleckes, Boris Schmitz, Malte Lenders, et al.
Journal of the American Society of Nephrology : JASN|May 3, 2015
Serum-Mediated Inhibition of Enzyme Replacement Therapy in Fabry DiseaseMalte Lenders, Jörg Stypmann, Thomas Duning, et al.
Frontiers in Physiology|July 21, 2018
The Yo-Yo Intermittent Tests: A Systematic Review and Structured Compendium of Test ResultsBoris Schmitz, Carina Pfeifer, Kiana Kreitz, et al.
Frontiers in Physiology|February 18, 2020
Sex Differences in High-Intensity Interval Training-Are HIIT Protocols Interchangeable Between Females and Males?Boris Schmitz, Hannah Niehues, Lothar Thorwesten, et al.
The Journal of Sports Medicine and Physical Fitness|February 24, 2017
Yo-Yo IR1 vs. incremental continuous running test for prediction of 3000-m performanceBoris Schmitz, Andreas Klose, Katrin Schelleckes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 29, 2016
Renal function predicts long-term outcome on enzyme replacement therapy in patients with Fabry diseaseMalte Lenders, Boris Schmitz, Jörg Stypmann, et al.
Plos One|August 30, 2014
Large vessel adventitial vasculitis characterizes patients with critical lower limb ischemia with as compared to without human immunodeficiency virus infectionMartin Brand, Angela J Woodiwiss, Frederic Michel, et al.
Chirurgia (Bucharest, Romania : 1990)|July 9, 2018
Managing Infected Pancreatic NecrosisJohn-Edwin Thomson, Sven M Van Dijk, Martin Brand, et al.
Pancreas|November 20, 2018
Transient Expression of Interleukin-21 in the Second Hit of Acute Pancreatitis May Potentiate Immune Paresis in Severe Acute PancreatitisJohn-Edwin Thomson, Ekene E Nweke, Martin Brand, et al.
Frontiers in Cardiovascular Medicine|November 29, 2023
Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry diseaseChristian Pogoda, Stefan-Martin Brand, Thomas Duning, et al.
Pageof 11